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ABSTRACT 
The conservation of great apes faces many challenges, one of which is the threat of infectious 
disease outbreaks. Zoonotic transmission of respiratory diseases from humans to wild great 
apes has recently been confirmed. Since respiratory disease is one of the major causes of 
death in both gorillas and chimpanzees, this gives reason for major concern.  
Little is known about the risks of disease transmission from humans to great apes in natural 
environments, and there is a need for systematic risk evaluation. Researchers, conservation 
staff and tourists spend time in very close proximity of wild great apes, sometimes during 
long time periods, which poses a potential risk of disease spillover. However, the presence of 
researchers and tourists has been shown to decrease the risk of poaching, making the matter 
increasingly complex. The risk of respiratory diseases of human origin affecting great apes 
can be minimized by hygienic rules and visitor regulations. Preventive measures can also be 
aimed directly at the apes through hands-on veterinary medicine. Direct intervention in wild 
populations through preventive or curative treatment is however a very controversial matter, 
since it risks interfering with evolutionary processes.  
Conservation medicine is a multidisciplinary science that cannot be isolated from ecology, 
ethology, human medicine or social sciences. Neither can the health and disease of wild great 
apes be separated from the health and disease of humans in the same area. A scientific, 
interdisciplinary approach is necessary in the aim for a standardized, systematic strategy to 
disease prevention and surveillance in endangered great ape populations.  
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SAMMANFATTNING 
Bevarandet av människoapor möter många utmaningar, bland annat risken för utbrott av 
infektiösa sjukdomar. Zoonotisk överföring av respiratoriska sjukdomar från människa till 
andra människoapor har nyligen bekräftats och är en anledning till oro, eftersom respiratorisk 
sjukdom är en av de främsta dödsorsakerna hos både gorillor och schimpanser i det vilda. 
Idag är kunskapen om riskerna för överföring av infektiösa sjukdomar från människor till 
människoapor i naturliga miljöer bristfällig och det finns ett behov av systematisk 
riskbedömning. Turister, forskare och parkpersonal spenderar ibland lång tid i 
människoapornas habitat, vilket utgör en risk för zoonotisk smittoöverföring. Samtidigt har 
närvaro av turister och forskare visat sig verka skyddande mot tjuvjakt – vilket gör detta till 
en komplex fråga. Risken för att humana respiratoriska sjukdomar ska drabba människoapor 
kan minimeras genom hygienbestämmelser och restriktioner som omfattar alla personer som 
vistas i deras habitat. Förebyggande åtgärder kan även riktas direkt mot människoaporna 
genom veterinära åtgärder, såsom vaccinationer eller annan medicinsk behandling. Direkta 
interventioner i vilda populationer är dock mycket kontroversiella, då de riskerar att inverka 
på evolutionära processer.  
Bevarandemedicin är en multidisciplinär vetenskap som inte kan särskiljas från studier inom 
ekologi, etologi, humanmedicin eller samhällsvetenskap. På samma sätt kan inte 
människoapornas hälsa särskiljas från hälsan hos de människor som lever och rör sig i samma 
områden. Ett vetenskapligt, interdisciplinärt angreppssätt är nödvändigt i strävan efter en 
standardiserad, systematisk strategi kring förebyggande arbete, hälsoövervakning och 
sjukdomsbekämpning i populationer av utrotningshotade människoapor.  
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INTRODUCTION 
On the International Union for Conservation of Nature (IUCN) Red List of Threatened 
Species, all great apes except humans are listed as endangered or critically endangered 
(IUCN, 2012). The great apes are: orang-utans (Pongo spp.), bonobos (Pan paniscus), 
chimpanzees (Pan troglodytes) and gorillas (Gorilla spp.). Chimpanzees and bonobos are 
most closely related to humans, but all great apes have very similar genetic makeup (Prufer et 
al., 2012). Due to this phylogenetic relationship, pathogens risk being transmitted between 
species. Although some of these pathogens might be harmless to humans, they may pose a 
great threat to previously unexposed individuals and populations of primates (Ott-Joslin, 
1993; Wallis and Lee, 1999; Ferber, 2000). On the other hand, infectious diseases that have 
emerged from non-human primates and caused outbreaks in humans have been studied quite 
extensively, for example in the cases of simian retroviruses (i.e. Calvignac-Spencer et al., 
2012; Peeters and Delaporte, 2012; Rault, 2012).  
Great ape conservation faces many challenges today, such as habitat fragmentation, 
deforestation, poaching and illegal trade with animals. However, disease – and respiratory 
disease in particular – is a major cause of death in many great ape populations (Cranfield, 
2008; Williams et al., 2008). Leendertz et al. (2006) point out that even a few lethalities can 
be detrimental for small, isolated populations. Furthermore, disease outbreaks can also have 
long-term negative effects on a population beyond the acute mortality. Ryan and Walsh 
(2011) describe recovery time as the total time a population suffers consequences of a disease 
outbreak, through effects on reproduction and behaviour. In their study, modelling showed 
that a single, low-mortality respiratory outbreak in gorillas has a recovery time of five years.   
Humans and great apes coming into close contact during conservation efforts and tourism has 
long been feared to cause fatal respiratory disease outbreaks through the zoonotic 
transmission of human pathogens (Wallis and Lee, 1999; Ferber, 2000; Leendertz et al., 
2006). This fear has recently been proven valid, as human viruses have been found in great 
ape populations (Kaur et al., 2008; Koendgen et al., 2008; Koendgen et al. 2010; Palacios et 
al., 2011). 
This paper reviews the current knowledge about human-to-great ape respiratory disease 
transmission and prevention, by investigating which respiratory diseases could potentially be 
transmitted from humans to great apes, and if effective strategies are available to prevent this 
from happening. This leads up to a crucial question: can human presence in great habitats be 
justified by the positive outcomes of conservation efforts – or are we doing more harm than 
good?  
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METHODS 
By using the databases Web of Knowledge, Scopus, CAB Abstracts and PubMed, the 
literature was searched for original articles and reviews about respiratory zoonoses in great 
apes. Search words included: anthroponoses, zooanthroponoses, zoonoses, primate*, great 
ape*, conservation, disease transmission, respiratory, emerging, bonobo*, gorilla*, orang-
utan*, orangutan*, and chimpanzee*. Reference lists were also used to broaden and extend 
the search.  
LITERATURE REVIEW  
Historically, there have been many reports of respiratory outbreaks of unknown aetiology in 
African great ape populations, where humans have often been the suspected source of 
infection (Wallis and Lee, 1999; Woodford et al., 2002; Boesch, 2008; Hanamura et al., 2008; 
Williams et al., 2008). The human respiratory pathogens that are suspected to cause disease in 
great apes are bacteria such as: Mycobacterium tuberculosis, Streptococcus pneumoniae and 
other bacterial pneumonias; and viruses including: parainfluenza, influenza, paramyxo-, 
rhino-, adeno-, pertussis and rubella viruses (Ott-Joslin, 1993; Homsy, 1999; Loomis, 2003). 
Reported respiratory outbreaks at selected chimpanzee field sites are summarized in 
Appendix 1. 
Confirmed pathogens in respiratory disease outbreaks 
Respiratory disease is the main cause of death in wild, human-habituated chimpanzees 
(Woodford et al., 2002; Lonsdorf et al., 2006; Williams et al., 2008), and the second most 
common cause of death in mountain gorillas (Cranfield, 2008). However, the causative agent 
of great ape respiratory disease outbreaks has only been identified in four cases (Kaur et al., 
2008; Koendgen et al., 2008; Koendgen et al., 2010; Palacios et al., 2011).   
In 2008, the first direct evidence of virus transmission from humans to wild great apes was 
published (Koendgen et al., 2008). Two human paramyxoviruses – human respiratory 
syncytial virus (HRSV) and human metapneumovirus (HMPV) – were identified in 
chimpanzee respiratory outbreaks in Taï National Park, Côte d’Ivoire. Through phylogenetic 
analysis, it was shown that the strains clustered within clades of circulating human pandemic 
viruses. The proximate cause of death was bacterial pneumonia, something that both HMPV 
and HRSV predispose for (Wallis and Lee, 1999; Woodford et al., 2002). Two new 
Streptococcus pneumoniae strains were identified. The strains were more closely related to 
human strains than to each other, indicating human origin. However, a non-human source of 
the bacteria could not be ruled out. Koendgen et al. (2008) concluded that researchers – who 
spend up to eight hours per day with chimpanzee groups – were the most likely source of 
infection. Historically, chimpanzee group mortality correlates with the group’s exposure to 
researchers. This researcher-exposure effect was shown most obviously during habituations, 
where great apes are made accustomed to human presence. Habituations are paramount to 
research and tourism, but also increase risk of disease transmission (Wallis and Lee, 1999; 
Woodford et al., 2002; Macfie and Williamson, 2010), since the habituation process likely 
poses the initial exposure to human pathogens in combination with stress. 
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Following two respiratory outbreaks in 2005 and 2006 in chimpanzee groups of Mahale 
Mountains National Park, Tanzania, investigations found that a human related chimpanzee 
strain of metapneumovirus (hrcMPV) was the causing agent of at least one of the outbreaks 
(Hanamura et al., 2008; Kaur et al., 2008). The strain was believed to be the same as that of a 
2003 outbreak at Mahale and when analysed, the strain also showed 94 % identity to the 
strain from Taï, described above (Koendgen et al., 2008). Due to the epidemiological 
characteristics of the outbreaks, Kaur et al. (2008) fear that hrcMPV has become enzootic in 
Mahale since 2003, thus risking new fatal outbreaks being caused in naïve groups due to 
migration of infected chimpanzees.  
Humans are the only known reservoir for HRSV and HMPV (Koendgen et al., 2008). The 
viruses are common sources of respiratory disease in humans and no vaccines are available 
(Ryan and Walsh, 2011). In captive environments, transmission of HRSV from humans to 
chimpanzees has been reported, as well as detection of antibodies against several other human 
pathogens (e.g. Szentiks et al., 2009; Schaumburg et al., 2012; Kooriyama et al., 2013). 
Kilbourn et al. (2003) compared levels of antibodies against selected viruses of Malaysian 
free-ranging orang-utans undergoing translocation, and semi-captive orang-utans housed at 
Sepilok Orangutan Rehabilitation Centre. It was found that the groups shared antibodies for 
11 out of 47 viruses, but levels of exposure to some viruses differed markedly. The 
prevalence of antibodies against respiratory viruses was low, albeit higher in the semi-captive 
group, which could be attributed to human presence.  
As well as in chimpanzees, HMPV has been detected in mountain gorillas. This was done in 
the Virunga National Park, Rwanda, after an outbreak in 2009 (Palacios et al., 2011). During 
the outbreak 11 out of 12 individuals in the group showed moderate to severe signs of illness. 
Due to the outbreak’s severity, five individuals were given antimicrobial treatment. Two 
untreated individuals died: one adult female and one infant. Human-related isolates of HMPV 
were detected in several tissues and serum in the adult, and in the lungs of the infant.  
Transmission and detection  
Transmission of respiratory disease occurs through aerosol or droplets (Ott-Joslin, 1993) and 
some pathogens can stay infectious in the environment for a very long time, allowing indirect 
transmission (Homsy, 1999; Woodford et al., 2002). The rainforest, where the forest floor is 
damp and warm, without direct sunlight, is an ideal environment for microbial survival and 
transmission.  
There are many difficulties in detecting and identifying respiratory pathogens in wild great 
apes. Many authors have pointed out that a knowledge gap exists concerning great ape health 
and disease (e.g. Homsy, 1999; Whittier et al., 2001; Leendertz et al., 2006), which is 
assigned to a few factors and circumstances. More specifically: field projects are often strictly 
observational, in remote locations. In these locations, veterinary personnel are often lacking, 
few diagnostic tests are available and both climate and scavengers make it difficult to perform 
post-mortem examinations and obtain good tissue samples. In addition to this, few non-
invasive methods are available to screen for disease in live animals, and the behaviour of the 
species sometimes make it hard to observe the same individual continuously.  
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Health surveillance  
Health surveillance programs are in place in many of the great ape conservation programs 
(Leendertz et al., 2006; Koendgen et al., 2008; Smiley et al., 2010). In Gombe National Park, 
Tanzania, behavioural data from chimpanzees has been recorded since the 1960’s, and 
observation of health and disease has been included in ethograms from the start (Lonsdorf et 
al., 2006). However, recordings have differed depending on year and have sometimes been 
performed non-systematically. During the years of 2001-2003 chimpanzee health assessment 
was performed adhering to a systematic protocol, which was later modified to the one 
currently in use. It now includes information on behaviour, body condition, lameness, faecals 
and specific signs of respiratory illness.  
Non-invasive methods are valuable tools in the screening of disease in wild animal 
populations. Faecal samples from great apes have been collected and used in analysis of 
intestinal flora, systemic diseases and parasites (e.g. Goldberg et al., 2007; Gillespie et al., 
2008; Rwego et al., 2008). Moreover, faecals have recently been shown to be of use also to 
detect respiratory diseases in chimpanzees (Kaur et al., 2008; Koendgen et al., 2010). To 
assess the validity of faecal samples as a detection method for HMPV and HRSV in 
chimpanzees, Koendgen et al. (2010) compared samples from symptomatic and asymptomatic 
individuals; during and between HRSV and HMPV outbreaks, as well as during outbreaks 
with unknown aetiological agent. The study showed that faecal samples are good predictors of 
outbreak status, and sample results correlated strongly with observations of symptoms and 
behaviour. Interestingly, sequences from the confirmed HRSV outbreak (Koendgen et al., 
2008) were identical to strains in faecal samples from an outbreak in Taï in 2005 with 
previously unknown aetiology. In mountain gorillas, methods have been developed for the 
collection of saliva from discarded food, preferably wild celery (Smiley et al., 2010). By 
collecting saliva, screening for pathogens can be performed and genetic analyses conducted. 
Saliva is useful for detecting pathogens that are not excreted in urine or faecals, which holds 
true for most respiratory viruses (Smiley et al., 2010).  
Preventive strategies 
In a review, Jefferson et al. (2008) examined the evidence for effectiveness of different 
preventive measures against respiratory virus transmission during human pandemics. They 
concluded that a cheap and effective way of reducing spread is implementing barriers, 
hygienic measures such as the wearing of gloves and facemasks, and isolating persons with 
suspected infection. The reviewed articles often describe that compliance with different 
preventive strategies is a problem. Therefore the authors argue that it is problematic to 
achieve compliance during long-term interventions.  
There are two different – but not necessarily exclusive – approaches to the prevention of 
human-originated disease outbreaks in great apes (Deem et al., 2001; Ryan and Walsh, 2011). 
Either, the apes are the targets of the efforts in a hands-on approach, by preventing infection 
though vaccinations, or, if disease is a fact – treating the animals with available means. 
Alternatively, humans are the main targets of efforts in a hands-off approach, for example by 
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hygienic and behavioural restrctions, and through health programs for staff and researchers, 
including vaccinations (Cranfield, 2008; Boesch, 2008).  
Prevention through human health  
Possible human sources of zoonotic pathogens include local populations, poachers, tourists, 
researchers and conservation personnel, such as park rangers and guides (The Mountain 
Gorilla Veterinary Project 2002 Employee Health Group, 2004). Compliance with preventive 
measures is still a big problem at great ape field sites, with researchers and park personnel, as 
well as tourists (Wallis and Lee, 1999; Woodford et al., 2002; Lukasik-Braum and Spelman, 
2008; Macfie and Williamson, 2010; Ryan and Walsh, 2011). At an orang-utan rehabilitation 
centre in Sepilok, Malaysia, a questionnaire concerning immune status and perceived disease 
symptoms was answered by visiting tourists (Muehlenbein et al., 2010), where 15 % of the 
tourists reported to experience signs of disease at the time of their visit. Studies at African 
great ape-tourism sites have unfortunately shown similar results (Macfie and Williamson, 
2010). 
The health status of researchers and conservation staff is especially important to monitor, 
since they come into very close proximity of great apes, sometimes for long periods of time. 
At Parc National des Volcans, Rwanda, an employee health program was initiated in 2001 
with the goals of improving staff health and finding critical control points to minimize the risk 
of disease transmission (The Mountain Gorilla Veterinary Project 2002 Employee Health 
Group, 2004). In trying to find which parameters were of importance to health status, 
questions concerning staff’s perceived health, in addition to work- and living situations, were 
included in the health check-up. Of the persons in the survey, 24% reported to have 
experienced disease symptoms within the past month. The most common symptoms were 
cough and fever – both characteristic of respiratory infections. Despite this, 80% of the staff 
reported that they had no absence from work due to illness in the past 6 months. 
Hygiene standards and visitor regulations 
Rules on hygiene and visitor behaviour are based on three foundational ideas: decreasing 
human presence, decreasing pathogen introduction and limit the risk of contamination 
(Leendertz and Boesch, 2013). Different rules and regulations exist for tourists, researchers 
and conservation staff at major African chimpanzee field sites. These can include: the wearing 
of facemasks, proper disposal of waste, prohibition against symptomatic individuals entering 
the forest, a limit to the number of visiting groups per day, time-limited visits, minimum 
human-ape distance requirements, hygiene barriers, quarantine for foreign researchers, and 
vaccination requirements (Kaur et al., 2008; Lukasik-Braum and Spelman, 2008; Williams et 
al., 2008; Leendertz and Boesch, 2013). Unfortunately, the rules are often broken when 
revenue and comfort takes precedence over safety (e.g. Woodford et al., 2002; Lukasik-
Braum and Spelman, 2008; Macfie and Williamson, 2010). 
The first visitation rules for mountain gorillas were implemented as early as 1985 and revised 
in 1999 (Lukasik-Braum and Spelman, 2008). Rwandan, Congolese and Ugandan 
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governments all regulate tourist numbers and human-gorilla distances. In the Congo visitors 
must wear masks whilst in gorilla habitat (Palacios et al., 2011).  
Information is very scarce about which preventive measures are implemented against disease 
transmission from humans to orang-utans and bonobos. Some local guidelines exist for wild 
orang-utan tourism, where the basic aims are to minimize impact on vegetation and orang-
utan social interactions, by for example never allowing tourists to exit vehicles such as boats 
or cars while viewing orang-utans (Macfie and Williamson, 2010). In comparing health 
evaluations of free-ranging and semi-captive orang-utans Kilbourn et al. (2003) discuss the 
importance of eliminating nonessential interspecies contact, overcrowding, dietary imbalances 
and stress in sanctuary populations, to prevent disease transmission.  
Intervention 
According to The Mountain Gorilla Veterinary Project 2002 Employee Health Group (2004), 
the use of vaccines in the great ape populations is not practical and, according to some, not 
ethical. Hence, efforts targeting park staff and researchers should be considered a veterinary 
precautionary strategy. On the contrary, Ryan and Walsh (2011) state that a completely 
hands-off approach is no longer enough to balance the risk of fatal disease outbreaks in great 
ape populations. They instead argue for using vaccines and possibly curative treatment. The 
authors do however stress that all interventions must continuously be evaluated for safety, 
cost-efficiency and effectiveness. Hands-on veterinary intervention is a very controversial 
matter, since interventions risk interfering with evolutionary processes where pathogens 
would be a part of natural selection (Deem et al., 2001; Robbins et al., 2011). However, few 
species are unaffected by human intervention in some form, since even observational studies 
to impose a small change in ecology. In Taï National Park, the rule of thumb is that treatment 
against life threatening disease is performed, if the disease can be suspected to be of human 
origin (Leendertz et al., 2006). 
The Mountain Gorilla Veterinary Project, MGVP, was initiated in the 80’s with the goal of 
using a “One Health” approach to health and disease surveillance, aiming to improve the 
sustainability in mountain gorilla populations (Cranfield, 2008). This coalition was the first to 
use veterinary treatment and care for individual animals in the wild as part of disease control 
strategies. Initially, efforts were directed solely at the gorillas – through post-mortem 
examinations and interventions. Since 2000, human and domestic animal interventions are 
also included in the groups’ work, through initiatives such as the employee health programs 
described above. The mountain gorillas of the Virungas have increased in numbers since the 
80’s, directly due to human presence and interventions (Robbins et al., 2011). When 
comparing the survival of habituated and unhabituated groups, Robbins et al. (2011) found 
that conventional, non-interventionist approaches used in unhabituated groups, has led to a 
slight annual decline in population growth of –0.7% per year. This as compared to the 
habituated groups where the authors instead saw an annual growth of +4.1%. Both rates were 
compared to a modelled baseline of +3.1%, which only considers average reproduction and 
survival rates. The difference between the groups could be attributed to human presence, 
where 40% was calculated to be a result of direct veterinary interventions, and 60% due to the 
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increased monitoring and protecting against poaching. In the modelling, the authors also 
looked specifically at interventions during respiratory outbreaks. When calculating the change 
in growth rate if no veterinary treatment had taken place during respiratory outbreaks, the 
habituated groups’ growth would have dropped to +3.4%. The authors concluded that efforts 
that increase survival in a population, such as veterinary interventions, are more efficient than 
efforts aiming at increasing reproduction, when trying to increase growth. In accordance with 
the conclusions of Ryan and Walsh (2011), Robbins et al. (2011) stress that while 
conventional conservation approaches might be both cheaper and more in line with what is 
considered “natural”, they might not be enough anymore.  
DISCUSSION 
Ten years ago, Walsh et al. (2003) called for urgent measures to save the African great apes. 
Due to the rapid declines of the great ape populations in western equatorial Africa, the authors 
argued that all chimpanzee and gorilla species should be reclassified as critically endangered 
on the IUCN Red List. Still today, the conservation of great apes faces huge ordeals, without 
simple solutions. The threat of infectious disease outbreaks is only one alongside others, such 
as habitat loss, poaching and trade with live and dead animals. However, great ape disease is 
receiving more and more attention, as it is being realized that this threat is not one to 
overlook. Many outbreaks are feared to originate from humans, most probably researchers 
and conservation staff. At the same time, the presence of researchers and tourists has been 
shown to decrease poaching (Cranfield, 2008; Koendgen et al., 2008; Robbins et al., 2011). 
The question remains: is human presence in great ape habitat causing more harm than good?  
The knowledge gap 
There is a lack of reports, not only about the human-great ape disease transmission, but also 
about enzootic diseases, normal physiological parameters, which pathogens are in fact 
zoonotic in natural settings, and risks for and consequences of disease transmission from 
humans (e.g. Kilbourn et al., 2003; Lonsdorf et al., 2006; Koendgen et al., 2010; Ryan and 
Walsh, 2011). Many authors have called for precautionary, offensive strategies to prevent 
disease transmission to great apes, together with systematic screening, impact analysis and 
baseline data on great ape health (e.g. Whittier et al., 2001; Leendertz et al., 2006; Lonsdorf et 
al., 2006; Cranfield, 2008; Gillespie et al., 2008; Ryan and Walsh, 2011). The need for 
research in wild great ape health cannot be understated, since historical evidence of disease is 
mostly anecdotal or strictly observational. If health and disease would be studied in a more 
systematic manner, knowledge would be gained that allows for acting proactively in being 
able to recognize outbreaks earlier on, or hopefully preventing them altogether (Leendertz, 
2008). Ryan and Walsh (2011) specifically stress the need for impact analysis of zoonotic 
pathogen transmission, since no study as of yet has addressed the true risk of disease spillover 
from humans in a scientific manner. For example: the use of facemasks or the restrictive 
minimum visitor distances have never been properly evaluated. The lack of impact analysis is 
also being addressed as a concern in the IUCN Best Practice Guidelines for Great Ape 
Tourism (Macfie and Williamson, 2010).  
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Today, we do not know for certain which human respiratory infections are high-risk for 
infecting great apes, although viruses have been shown to cross species barriers to a greater 
extent than bacteria (Pedersen and Davies, 2009). Our knowledge on disease transmission 
mostly originates from studies in captive environments (e.g. Szentiks et al., 2009; Kooriyama 
et al., 2013) and a few systemic studies of outbreaks in the wild (Koendgen et al., 2008; 
Koendgen et al., 2010; Palacios et al., 2011; Kaur et al., 2008). The studies conducted shed 
light on a reality where many human respiratory pathogens can be transmitted to at least 
chimpanzees and gorillas. There is little knowledge about the effect a natural environment has 
on both host and pathogen (Whittier et al., 2001). However, it has been shown that the 
pandemic human viruses HMPV and HRSV have penetrated the species barrier to wild great 
ape populations (Koendgen et al., 2008, Palacios et al., 2011), which is a reason for great 
concern and caution.  
The impact of tourism 
Tourism is not only an important source of income, but has been shown to lessen poaching in 
African national parks (Cranfield, 2008; Koendgen et al., 2008; Robbins, et al., 2011). Even 
though tourists might spend less time in great ape groups than researchers (The Mountain 
Gorilla Veterinary Project 2002 Employee Health Group, 2004), tourists are an important 
group to target in the prevention of disease transmission. The lack of understanding of the 
disease transmission risk is evident in the works by Muehlenbein et al. (2010) and The 
Mountain Gorilla Veterinary Project 2002 Employee Group (2004). Both reports show that 
despite showing disease symptoms and knowing about existing rules and regulations, both 
staff and tourists enter forests to go into near proximity of endangered great apes.  
The importance of the existing regulations must be stressed to tourists, already during the 
booking process, with a clause stating that persons showing respiratory symptoms will be 
prohibited to go on the trek. When prohibiting sick tourists from entering the forest, all staff 
and stakeholders need to be informed that it is not the maximum number of visitors that gives 
success in the long-term (Ryan and Walsh, 2011). Prohibition of sick visitors might represent 
a short-term financial set back, but will in the long run help sustain the populations so that 
tourism can continue. Trekking for great apes is a once-in-a-lifetime experience, and those 
who do it likely have a genuine interest in the conservation of these animals. According to 
Lukasik-Braum and Spelman (2008), it should not be assumed that the tourists view visitation 
regulations as negative – maybe even the contrary.  
The 2002 Orang-utan Conservation and Reintroduction Workshop emphasized that tourism 
should not be allowed in rehabilitation centres, and it also advised against further tourism 
initiatives in wild orang-utan habitat (Macfie and Williamson, 2010). Orang-utan sanctuaries 
and rehabilitation centres in Indonesia and Malaysia are popular tourist attractions, where 
close contact between humans and orang-utans presents a risk for transmission of disease. 
These animals are sometimes completely habituated, which according to the IUCN guidelines 
makes these centres dubious conservation tools. The shown differences in the prevalence of 
antibodies against different pathogens in captive and semi-captive populations of orang-utans 
is a problem that Kilbourn et al. (2003), concluded must be borne in mind when translocating 
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or re-introducing animals into the wild from shelters and rehabilitation centres, since this 
could potentially introduce pathogens to naïve wild animals. 
Interventions 
In the event of disease outbreaks, and specifically if transmission of disease from humans 
does occur, should we intervene and medically treat wild animals in a progressive, hands-on 
manner, or should we refrain from direct veterinary treatments in wild populations all 
together? To a great extent, this is an ethical question. Where should time, efforts and money 
be invested? How can a large-scale health or vaccination program be justified in a gorilla or 
chimpanzee population, when no health programs exist in the human populations that 
surround the national parks? Unfortunately the ethical considerations extend beyond the scope 
of this paper. However, no scientific report or study can answer the question if it is right to 
intervene. What we do know, is that the great apes have been pushed towards extinction by 
human activities. When humans now try to conserve the remaining populations, should we 
not try and do everything we can? Hopefully, great ape habitats will one day be respected and 
protected. By then, we need to have done everything we can in order to ensure that there are 
still viable populations left. Robbins et al. (2011) showed that human presence and veterinary 
interventions has had a substantial effect on population growth rates in mountain gorillas. 
Since this and other studies indicate that human presence does in fact lead to increasing 
growth rates (Cranfield, 2008; Koendgen et al., 2008), the risks of disease transmission that 
come with human presence might be outweighed. 
Veterinary interventions in wild populations are often seen as not being “natural”. However, 
few species are unaffected by human intervention in some form, since even field observations 
do impose a small change in ecology. This is why Deem et al. (2001) argue that the 
discussion should not be about whether or not to intervene – but in what way. The authors 
state that it is no longer ethically defendable to cling on to a hands-off approach in 
conservation, especially not when battling disease. The use of available, safe vaccines against 
human pathogens that are suspected to be of danger to great apes should not be discarded on 
the grounds of it being too invasive. Neither should the use of curative treatment. 
Nevertheless, all actions or treatments – proactive or reactive – must be preceded by hazard 
analysis and risk assessment, and followed by evaluation. Assessments and evaluations 
should be done in a systematic manner, based on objective science, and shared with others in 
order to maximize benefit.  
The Great Ape Health Monitoring Unit (GAHMU) is an international network that collects 
baseline data on general physiology and disease of great apes, through systematic sampling 
and surveillance (Leendertz and Boesch, 2013). One aim is to perform systematic risk- and 
impact analyses concerning disease transmission (Leendertz et al., 2006; Leendertz, 2008). 
The network hopes to make more validated diagnostic tests available for rapid pathogen 
detection in the field, which would lead to an increased readiness to act in the event of an 
outbreak in great ape, and potentially also human, populations.  
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Final remarks  
Finding consensus and uniformity in the way health surveillance of the great apes is conveyed 
is valuable for validity and comparison of data. All examinations conducted – such as sample 
collection and post-mortem necropsies – should always be done according to established 
protocol, which should be continuously revised. The initiatives of GAHMU, and projects such 
as MGVP are necessary and promising for the future of great ape conservation.  
There is an urgent need for a stronger connection between the research on zoonotic disease 
risk, and all persons that come into contact with great apes. Every person must wholly realize 
that his or her own behavior can potentially put the great apes at risk for contracting human 
diseases, and only researchers knowing about the risks will not increase compliance to rules 
and restrictions. To achieve increased compliance, risk communication and education needs 
to improve. Through popular science, current knowledge can be conveyed to the public, 
including the tourists that visit great ape habitat every year.  
Finally, great ape conservation medicine in its true form cannot – and should not – be isolated 
from research in ecology, ethology, human medicine and social sciences. Neither can the 
health and disease of wild great apes be separated from the health and disease of human 
populations inhabiting the same area. Interdisciplinary approaches are needed – where 
combined efforts, combined knowledge, and work on several fronts form systematic, uniform 
strategies to minimize the risk of human-to-great ape disease transmission.  
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Appendix 1. Summary of respiratory outbreaks at selected African chimpanzee field sites 
  
* - Confirmed and suspected morbidity and mortality respectively, due to missing individuals 
 Outbreak Group morbidity; 
mortality 
Pathogen Examinations References 
Mahale Mountain 
National Park, 
Tanzania 
1993 NA; 11% NA NA (Kaur et al., 
2008, 
Hanamura et 
al., 2008, Ryan 
and Walsh, 
2011) 
1994 NA; 15%  NA NA 
2003 98%; 7%  NA NA 
2005 52%; 3%  Paramyxovirus suspected Necropsy, faecal samples, electron 
microscopy (EM) 
2006 35%; 5% or 48%; 19%* hrcMPV  Necropsy, faecal samples (viral PCR-
assay), EM 
Gombe National Park, 
Tanzania 
1968 63%; 8% NA NA (Wallis and 
Lee, 1999, 
Lonsdorf et al., 
2006, Williams 
et al., 2008)  
 
1975 NA; 1 individual NA NA 
1978 NA; 1 individual NA NA 
1987 40%; 17% NA NA 
1996 NA; 11 individuals  NA NA 
2000 75%; 4% S. pneumoniae; S. pyogenes  Samples  
2002 NA; NA NA NA 
Taï National Park, 
Côte d’Ivoire 
1999  100%; 19% HRSV; S. pneumoniae 
strain 2308  
Necropsy, histology, PCR-methods, 
faecal samples  
(Koendgen et 
al., 2008, 
Koendgen et 
al., 2010) 
2004  100%; 18% HMVP; S. pneumoniae 
strain 2309; P. multocida  
2006a  92%; 3% HRSV; S. pneumoniae 
strain 2309  
2006b  NA; NA HRSV; S. pneumoniae 
strain 2308  
